| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 99.712 | 91.917 | 121.149 | 134.188 | 137.143 | 112.116 | 141.146 | 175.840 | 176.204 | 160.141 |
| Total Income - EUR | 99.742 | 93.960 | 121.172 | 134.198 | 137.657 | 172.917 | 141.146 | 191.049 | 178.943 | 160.141 |
| Total Expenses - EUR | 89.243 | 88.116 | 107.411 | 108.929 | 105.274 | 135.183 | 101.555 | 128.175 | 148.205 | 152.092 |
| Gross Profit/Loss - EUR | 10.499 | 5.844 | 13.762 | 25.269 | 32.383 | 37.733 | 39.591 | 62.874 | 30.738 | 8.049 |
| Net Profit/Loss - EUR | 7.238 | 4.909 | 4.677 | 23.927 | 31.007 | 36.721 | 38.349 | 61.002 | 29.249 | 4.411 |
| Employees | 5 | 4 | 3 | 4 | 3 | 3 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Cytopath Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 95.122 | 121.611 | 113.778 | 99.930 | 88.261 | 41.438 | 37.328 | 97.603 | 82.521 | 72.077 |
| Current Assets | 78.666 | 77.083 | 91.483 | 115.381 | 140.433 | 139.991 | 172.248 | 115.323 | 105.544 | 100.728 |
| Inventories | 846 | 18.665 | 824 | 2.709 | 176 | 55 | 0 | 1.237 | 0 | 0 |
| Receivables | 52.214 | 52.653 | 53.390 | 44.449 | 44.168 | 24.074 | 23.077 | 70.497 | 108.661 | 101.977 |
| Cash | 25.606 | 5.765 | 37.270 | 68.223 | 96.090 | 115.862 | 149.171 | 43.590 | -3.117 | -1.249 |
| Shareholders Funds | 76.725 | 65.265 | 68.837 | 91.501 | 120.736 | 145.811 | 180.926 | 111.209 | 84.250 | 71.771 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 97.127 | 133.430 | 136.423 | 123.809 | 108.108 | 35.850 | 29.097 | 102.085 | 104.075 | 101.523 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Cytopath Srl